Sponsor of the Day:
Jerkmate
https://www.arcutis.com/pipeline/
Pipeline - Arcutis Biotherapeutics
Oct 6, 2025 - Explore Arcutis’ pipeline of best-in-class molecules developed from key targets of inflammatory dermatological conditions.
arcutis biotherapeuticspipeline
https://www.arcutis.com/pipeline/arq-234/
ARQ-234 - Arcutis Biotherapeutics
Feb 24, 2026 - ARQ-234 is a fusion protein that serves as an agonist with high selectivity and potency for the CD200 receptor (CD200R).
arcutis biotherapeuticsarq234
https://www.zacks.com/stock/quote/ARQT
Arcutis Biotherapeutics - ARQT - Stock Price Today - Zacks
stock price todayarcutis biotherapeuticszacks
https://www.greatplacetowork.com/certified-company/7037825
Working at Arcutis Biotherapeutics | Great Place To Work®
Is Arcutis Biotherapeutics a great place to work for?
arcutis biotherapeuticsgreat placeworking
https://thedermdigest.com/arcutis-submits-snda-to-the-us-fda-for-roflumilast-cream-0-05-in-infants-with-ad/
Arcutis Submits sNDA to the US FDA for Roflumilast Cream 0.05% in Infants With AD - The Dermatology...
Apr 28, 2026 - Arcutis submitted a sNDA to the FDA seeking to expand the indication for roflumilast cream 0.05% to infants down to 3 months.
cream 0 05us fdaarcutissubmitsinfants
https://www.arcutis.com/products/zoryve-cream/
ZORYVE (roflumilast) cream - Arcutis Biotherapeutics
Apr 30, 2026 - Explore a list of Arcutis Biotherapeutics immune-dermatology products.
arcutis biotherapeuticscream
https://www.arcutis.com/
Arcutis Biotherapeutics - Medical dermatology innovation
Jan 7, 2026 - Learn how Arcutis is advancing the treatment of immune-mediated skin diseases like seborrheic dermatitis, psoriasis, and eczema through topical treatment...
arcutis biotherapeuticsmedical dermatologyinnovation